Platforms

Patented Platform

Our platform to engineer synthetic short RNA binder for optimal affinity, sensitivity, reproducibility to shape Therapeutics (Tx), Drug Diagnostic Co-Development (DDxC) and Diagnostics (Dx)

synthetic short RNA processed by active protein

synthetic short RNA binding to any protein or peptide

synthetic short RNA binding to PTMs, isoforms, conformations

multiplexing

RNA and DNA in situ in 1 shift

low viral copies without enzymes

Scroll to Top